Stay updated on LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Sign up to get notified when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.

Latest updates to the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page
- CheckyesterdayChange DetectedAlcohol Use Disorders Identification Test was removed from the page, indicating that alcohol-use screening is no longer specified as part of eligibility or assessment.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page now shows a new Revision: v3.5.3, replacing the previous v3.5.2, indicating an updated document version on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check44 days agoChange DetectedPublications updated: added Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges (NEJM 2026 Feb 26) and removed the earlier NEJM Online ahead of print entry (Feb 18, 2026).SummaryDifference0.0%

- Check51 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.4.3 is now listed, replacing v3.4.2.SummaryDifference0.0%

Stay in the know with updates to LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.